NIH-funded research R21 grant

Plasma membrane rupture in alcohol-associated hepatitis

Funded at Tulane University of Louisiana · NIH-11423664 · Data updated 2026-11-12

This grant explores how bile flow problems in alcohol-related liver disease might drive a specific cell-damage process, with the goal of finding new ways to help people with severe liver disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 26, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$181,688
NIH project number5R21AA031728-02
Project IDNIH-11423664 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with alcohol-related liver disease or alcohol-associated hepatitis in whom new diagnostics or treatments could be developed from the researchers’ findings.

Less likely to help

Patients without cholestasis or without the specific pathway investigated may not directly benefit from these findings.

What this research studies

Alcohol-associated hepatitis can be life-threatening and often involves cholestasis, which may worsen outcomes. The research will look at how cell membrane rupture, a damaging form of cell death, occurs in liver cells during ALD and whether cholestasis promotes this process. By studying the mechanisms in preclinical models, the project aims to identify potential targets for diagnosis and therapy that could translate to patients with AH. The work focuses on two aims: understanding the role of membrane rupture in ALD and how cholestasis influences this process in hepatocytes.

Why it matters

Potential benefit: If successful, the work could lead to new diagnostic markers and therapies that reduce liver damage in people with alcohol-associated hepatitis.

How similar studies have gone: Previous studies have shown that membrane rupture and inflammatory cell death contribute to liver injury, but the exact role of cholestasis in promoting PMR in ALD is not yet defined.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Yan, Shengmin — Tulane University of Louisiana
  • Study coordinator: Yan, Shengmin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.